Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma

2019912 citationsJournal Articlebronze Open Access

Authors

Yuan Zhang · Sun Yat-sen University

Lei Chen · Sun Yat-sen University

Guoqing Hu · Tongji Hospital

Ning Zhang · First People's Hospital of Foshan

Xiaodong Zhu · Guangxi Medical University

Kunyu Yang · L-3 Communications (United States)

Feng Jin ·

Abstract

Induction chemotherapy added to chemoradiotherapy significantly improved recurrence-free survival and overall survival, as compared with chemoradiotherapy alone, among patients with locoregionally advanced nasopharyngeal carcinoma. (Funded by the Innovation Team Development Plan of the Ministry of Education and others; ClinicalTrials.gov number, NCT01872962.).

Topics & Keywords

Head and Neck Cancer Studies Head and Neck Surgical Oncology Lung Cancer Research Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 381, Issue 12, pp. 1124-1135

DOI: 10.1056/nejmoa1905287

Field-Weighted Citation Impact: 90.17